Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study.

PA requirements are associated with treatment delays and denials are associated with greater glucocorticoid exposure. Because the great majority of PA requests are ultimately approved, the value of PA requirements and their impact on patient safety should be reevaluated.